Endogenous cannabinoids may regulate chronic inflammation in aspirin-exacerbated respiratory disease
Aspirin-exacerbated respiratory disease (AERD) is characterized by the triad of chronic rhinosinusitis with nasal polyposis, adult-onset asthma and non-IgE mediated reactions to aspirin and other cyclooxygenase-1 (COX-1) inhibitors. Patients with AERD are dependent on COX-1 activity to maintain prod...
Guardado en:
Autor principal: | Joshua M. Levy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/339297f3f15043c4ab6019e7b26d2267 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety
por: Kathleen Buchheit, et al.
Publicado: (2020) -
Aspirin-exacerbated respiratory disease: Update on medical management
por: Andrew A. White, et al.
Publicado: (2020) -
Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Lindsey Ryan, et al.
Publicado: (2020) -
Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis
por: Daniel B. Spielman, et al.
Publicado: (2020) -
Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Ethan G. Muhonen, et al.
Publicado: (2020)